BGMD Stock News 1.27 05/13/2014 19:17:28 Bg Medicine (BGMD)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Bg Medicine (BGMD) 1.27 $BGMD

Covance Posts In-line Q1 Earnings; Falls on Trimmed View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 08, 2:30PM CDT
Covance (CVD) reported adjusted earnings per share (EPS) of 90 cents in the first quarter of 2014.

BG Medicine Announces Q1 2014 Financial Results Release Date and Conference Call Information
GlobeNewswire - Wed May 07, 3:47PM CDT
BG Medicine, Inc. (Nasdaq:BGMD) today announced that the company will host a conference call and webcast on Wednesday, May 14, 2014 at 8:30 a.m. Eastern Time to discuss its Q1 2014 financial results before the market opens.

PAREXEL Q3 Earnings & Revs Beat Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 30, 2:00PM CDT
For fiscal 2014, PAREXEL International Corporation (PRXL) increased its adjusted EPS guidance to a range of $2.11 to $2.15 from the prior range of $2.01 to $2.11.

Healthways Up on Narrower-than-Expected Q1 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 28, 6:55AM CDT
Shares of Healthways Inc. (HWAY) jumped nearly 11.3% after the company reported better than expected first-quarter results to close at $18.16 till the last reported session.

IPC The Hospitalist (IPCM) in Focus: Stock Slumps 12.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 25, 7:43AM CDT
IPC The Hospitalist falls 12.2% last trading session, continuing the downtrend

DaVita Expands, Strengthens Florida Presence - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 22, 5:40PM CDT
DaVita, the kidney care division of DaVita HealthCare Partners Inc., has recently declared the expansion of its diagnostic laboratory DaVita Labs.

Coverage of Health Care Sector Stocks -- Research on Agilent Technologies, Thermo Fisher Scientific, Nordion, and BG Medicine
PR Newswire - Tue Apr 15, 10:08AM CDT
On Monday, April 14, 2014, the NASDAQ Composite ended at 4,022.69, up 0.57%, the Dow Jones Industrial Average advanced 0.91% to 16,173.24, and the S&P 500 closed at 1,830.61, up 0.82%. The gains were broad based as all the 10 sectors ended the session in positive. The S&P 500 Health Care Sector Index finished the day at 648.05, up 0.51%, while the same has declined 3.97% in the last one month. Investor-Edge has initiated coverage on the following equities: Agilent Technologies Inc. (NYSE: A), Thermo Fisher Scientific Inc. (NYSE: TMO), Nordion Inc. (NYSE: NDZ) and BG Medicine Inc. (NASDAQ: BGMD). Free technical research on A, TMO, NDZ and BGMD can be downloaded upon signing up at:

Clinical Trial Results Presentation and Publication, and Upcoming Exhibit - Analyst Notes on Gilead Sciences, Agios, Mindray, BG Medicine, and Ultragenyx
PR Newswire - Wed Apr 09, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Gilead Sciences, Inc. (NASDAQ: GILD), Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), Mindray Medical International Limited (NYSE: MR), BG Medicine, Inc. (NASDAQ: BGMD), and Ultragenyx Pharmaceutical, Inc. (NASDAQ: RARE). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

Barnes & Noble Sinks after Liberty Media Sells Off Big Stake; Adobe Systems Insiders also Sell off Shares
ACCESSWIRE - Thu Apr 03, 11:21PM CDT
Barnes & Noble, Inc. (NYSE: BKS) - For an in-depth report on Barnes & Noble, Inc. follow: www.BullTrends.com/stockquote/BKS

Why BG Medicine (BGMD) Is Tumbling on Thursday
at The Street - Thu Apr 03, 11:25AM CDT
BG Medicine (BGMD) is plummeting on Thursday in response to its pricing of common stock in its latest public offering.

BG Medicine, Inc. Prices $10.0 Million Public Offering of Common Stock
GlobeNewswire - Thu Apr 03, 8:15AM CDT
BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3 Test, today announced the pricing of the sale of 6,452,000 shares of its common stock in an underwritten public offering at a price to the public of $1.55 per share. The net offering proceeds to BG Medicine from the sale of the shares are expected to be approximately $8.9 million, after deducting underwriting discounts and commissions and other estimated offering expenses, but excluding any exercise of the underwriter's over-allotment option.

Hewlett-Packard to Enter the 3d Printing Market; BG Medicine Announces Positive Data from Clinical Research Trials
ACCESSWIRE - Tue Mar 25, 11:25PM CDT
Hewlett-Packard Company (NYSE: HPQ) - For an in-depth report on Hewlett-Packard Company follow: www.BullTrends.com/stockquote/HPQ

Most active Nasdaq-traded stocks
AP - Tue Mar 25, 12:35PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:

Publication Reports Clinical Utility of BGM Galectin-3(R) Test for Prediction of Near-Term Rehospitalization in Patients With Heart Failure
GlobeNewswire - Tue Mar 25, 7:31AM CDT
BG Medicine, Inc. (Nasdaq:BGMD) announced today the publication of results, in the American Heart Journal, of an analysis of aggregated data from three large, multicenter clinical research trials in the United States and Europe. The trials included a total of 902 heart failure patients and demonstrated that elevations of galectin-3 levels in blood, as measured using the BGM Galectin-3(R) Test, were significantly predictive of rehospitalization for heart failure as early as within the first 30 days following discharge from an initial hospital stay. [1]

Lawsuits, Clinical Studies, Financial Results, and Stock Movements - Analyst Notes on Idenix, BG Medicine, Progenics, Omeros, and Opexa
PR Newswire - Fri Mar 21, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Idenix Pharmaceuticals Inc. (NASDAQ: IDIX), BG Medicine, Inc. (NASDAQ: BGMD), Progenics Pharmaceuticals Inc. (NASDAQ: PGNX), Omeros Corporation (NASDAQ: OMER), and Opexa Therapeutics, Inc. (NASDAQ: OPXA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register http://www.analystsreview.com/register

Insider Buying Is On The Rise In These 4 Rallying Stocks
at The Street - Thu Mar 20, 5:16PM CDT
James Dennin, Kapitall: One way to evaluate small cap stocks is by looking for insider buying, when people on staff are buying [...]

Why BG Medicine (BGMD) Hit a One-Year High Today (Update)
at The Street - Thu Mar 20, 3:41PM CDT
BG Medicine (BGMD) rose to a one-year high of $2.36 on Thursday after the diagnostics company reported fourth-quarter results that beat analysts' expectations. BG Medicine reported a loss of 6 cents a share, which beat the Capital IQ consensus...

BG Medicine Announces Issuance of Patent Covering Galectin-3 Testing for Cardiac Resynchronization Therapy
GlobeNewswire - Thu Mar 20, 7:14AM CDT
BG Medicine, Inc. (Nasdaq:BGMD) today announced that on March 18, 2014, the United States Patent and Trademark Office issued patent 8,672,857, titled "Galectin-3 and Cardiac Resynchronization Therapy," to the Company. The patent claims methods for predicting responsiveness to cardiac resynchronization therapy by the measurement of the concentration of the protein galectin-3 in blood.

BG Medicine Reports 2013 Fourth Quarter and Year End Financial Results
GlobeNewswire - Thu Mar 20, 6:50AM CDT
BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3 Test, today reported financial results for the three months ended and year ended December 31, 2013.

The Next Big Biotech Mover: Ariad Pharma
at The Street - Wed Mar 19, 1:00PM CDT
Ariad Pharmaceuticals could be the next biotech stock setting up for a monster move higher, according to Roberto Pedone.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tronox Pushes Back on Creditor Restructuring Chatter Firmly

Updated Category News Views 115

A Creditor Rumor Is Not a Restructuring Plan Two creditor groups hiring law firms can make a stock chart look like it stepped on a rake, but it is not the same thing as a debt workout. That distinction is the whole point of Tronox Holdings' November 18 update. A November 17 Wall Street Journal report said two groups of creditors had retained firms described as...

Continue Reading
Schloss Johannisberg Leads 2026 Global Vineyard List

Updated Category News Views 106

A 1,200-year-old riesling estate just beat the world at being memorable. Schloss Johannisberg in Germany’s Rheingau has taken No. 1 in The 50 Best Vineyards 2026, moving up from No. 2 last year and also claiming Best Vineyard in Europe. For anyone watching the wine business from the outside, this is not really a story about one bottle edging out another. It is a...

Continue Reading
Frosty Animatronics Put Nostalgia on Lowe's Shelves

Updated Category News Views 127

A moving corncob pipe is not anybody's idea of a macroeconomic signal, yet holiday aisles are built on precisely these little jolts of recognition. Gemmy has teamed with Warner Bros. Discovery Global Consumer Products to place a new animated Frosty the Snowman collection exclusively at Lowe's for the 2026 holiday season. It is cheerful retail business, not earthshaking...

Continue Reading
BVM's Brookfield Headquarters Move Tests Growth Ambition

Updated Category News Views 119

A bigger office is rarely the exciting part of a growth story, yet it can reveal whether the machinery underneath is actually running hot. Best Version Media has moved its headquarters from Janacek Court to 15800 W. Bluemound Road, Suite 400, in Brookfield, Wisconsin, citing room for recent hires, future recruitment and closer collaboration across its print and digital...

Continue Reading
Roland DG's Brand Refresh Earns Three B2B Awards in 2026

Updated Category News Views 98

Three trophies for a printer-maker’s marketing overhaul will not move mountains by themselves, but they do tell us Roland DG has stopped treating its brand like an afterthought. The company’s global Make Your Mark refresh picked up two Silver awards and one Bronze at the 2026 Drum B2B Awards in Miami. For a business selling industrial-grade tools into crowded,...

Continue Reading
Trip.com Sets December 1 Date for Third-Quarter Results

Updated Category News Views 17

December’s first after-hours session will put Trip.com Group back under the market’s microscope, whether anybody is ready or not. The company says it will report results for the three months ended September 30, 2026 after the U.S. market closes on Tuesday, December 1. That is the whole hard-news payload for now: a reporting date, a call time, and no numbers to get...

Continue Reading
Tongwei's 846 MW Romania Deal Tests Solar Supply Scale

Updated Category News Views 5

Eight hundred forty-six megawatts of panels do not quietly roll out the factory gate. Tongwei’s supply agreement with Rezolv Energy for Romania’s Dama Solar project is a hefty piece of utility-scale solar business, and the first truckload has already left Tongwei’s Nantong facility. That matters more than another polished signing-ceremony photo: equipment is moving,...

Continue Reading
SHIFTAIon Puts Governance at Center of AI Migration

Updated Category News Views 69

Legacy code is where grand AI promises usually go to get mugged by reality. ACL Digital’s new SHIFTAIon platform is taking a sensible swing at that ugly problem: not merely generating code faster, but putting discovery, architecture decisions, testing, security checks, reviewer signoffs, and reporting into one controlled modernization process. That distinction matters....

Continue Reading
Banks Face a Choice: Retreat or Fund Climate Resilience

Updated Category News Views 26

A flooded field can turn a prudent loan book into a social retreat overnight. That is the uncomfortable nerve in the Global Alliance for Banking on Values paper unveiled at COP31 in Antalya on November 19, 2026. Banks have become very practiced at mapping physical climate exposure, raising prices, tightening standards and stepping away. Fine, risk discipline matters. But...

Continue Reading
Barcelona Housing Summit Puts Affordability on the Map

Updated Category News Views 12

A packed Barcelona hall cannot magically unjam a housing market, but it can force the grown-ups in the room to stare at the mess. Housing World Summit, known as HOWS Barcelona, closed its first edition with 1,530 attendees and a broad cast: city officials, governments, developers, investors, third-sector groups and academics. That mix matters because affordable housing is...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Share Buybacks and Voting Rights Dynamics

Updated Category News Views 130

Overview of Share Buybacks In recent financial news, Octopus AIM VCT plc has engaged in a strategic move by purchasing its own shares. This action is often a signal of confidence in the company's future and an investment in its own value. Details of the Transaction The company has recently announced the acquisition of 590,908 ordinary shares at a price of 47.27p each....

Continue Reading
Kojamo's Financial Report Highlights: Growth and Outlook

Updated Category News Views 186

Overview of Kojamo plc's Financial Performance Kojamo plc has recently published its financial report, highlighting significant changes and developments in their occupancy rates and revenues for the first half of the fiscal year. This report is particularly important for investors and stakeholders keen on understanding the company's financial health. Financial Highlights...

Continue Reading
Silicom Ltd. Partners with U.S. Firm for Edge Networking Growth

Updated Category News Views 167

Silicom Ltd. Partners with Provider for Edge Networking Solutions - $1 million annual run rate with potential for a significant multi-million-dollar scale-up - Silicom Ltd. (NASDAQ: SILC), a recognized leader in networking and data infrastructure solutions, has announced an exciting collaboration with a U.S.-based provider specializing in Edge networking solutions...

Continue Reading
Understanding the Ongoing Securities Case Against Five Below, Inc.

Updated Category News Views 120

Overview of the Class Action Lawsuit Against Five Below, Inc. As an investor, it's essential to stay informed about your rights, especially with ongoing legal matters. Currently, a notable class action lawsuit is underway involving Five Below, Inc. (NASDAQ: FIVE), which is particularly relevant for its shareholders. Class Period Details The allegations pertain to the time...

Continue Reading
Worthington Enterprises to Boost Portfolio with LSI Group Buyout

Updated Category News Views 169

Worthington Enterprises Expands Its Portfolio with Major Acquisition Worthington Enterprises Inc. (NYSE: WOR), renowned for its innovative designs and manufacturing prowess, has officially announced its intent to acquire LSI Group, LLC. This major acquisition positions Worthington Enterprises to enhance its offerings and market presence in the metal roofing sector....

Continue Reading